Furthermore, intratumoral, intertumoral, and interpatient heterogeneity in HLA-G isoform expression has been frequently observed, including in CRC, raising concerns about the precision of HLA-G-targeted cancer immunotherapy (11, 28, 31, 32). Here, HLA-G is linked to cancer.